Influence of Induction Therapy, Immunosuppressive Regimen and Anti-viral Prophylaxis on Development of Lymphomas After Heart Transplantation: Data From the Spanish Post–Heart Transplant Tumour Registry-Reference-Cited by-同舟云学术

Influence of Induction Therapy, Immunosuppressive Regimen and Anti-viral Prophylaxis on Development of Lymphomas After Heart Transplantation: Data From the Spanish Post–Heart Transplant Tumour Registry

Published:2007-11 Issue:11 Volume:26 Page:1105-1109
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Crespo-Leiro Maria G.,Alonso-Pulpón Luis,Arizón José M.,Almenar Luis,Delgado Juan F.,Palomo Jesús,Manito Nicolás,Rábago Gregorio,Lage Ernesto,Diaz Beatriz,Roig Eulalia,Pascual Domingo,Blasco Teresa,de la Fuente Luis,Campreciós Marta,Vázquez de Prada José A.,Muñiz Javier

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference18 articles.

1. Posttransplant lymphoproliferative disease in pediatric liver transplantation;Newell;Transplantation,1996

2. Persistence of the Epstein–Barr virus and the origins of associated lymphomas;Thorley-Lawson;N Engl J Med,2004

3. Non-Hodgkin’s lymphoma after kidney or heart transplantation: frequency of occurrence during the first posttransplant year;Opelz;Transplant Int,1994

4. Increased incidence of lymphoproliferative disorder after inmunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients;Swinnen;N Engl J Med,1990

5. Post-transplant lymphoproliferative disease in cardiac transplant patients receiving OKT3 therapy;Ratkovec;Clin Transplant,1992

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of de novo malignancy and all-cause mortality among heart transplant recipients;International Journal of Cardiology;2024-11

2. Temporal Trends, Risk Factors, and Clinical Outcomes of De Novo Lymphoproliferative Disorders After Heart Transplantation;JACC: Heart Failure;2024-02

3. Screening and Management of PTLD;Transplantation;2023-10-21

4. Malignancy among adult heart transplant recipients following patient‐tailored dosing of anti‐thymocyte globulin: a retrospective, nested case‐control study of individualized dosing;Transplant International;2021-09-23

5. Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review;American Journal of Kidney Diseases;2021-08